|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
1613092326 |
003 |
DE-627 |
005 |
20230905071116.0 |
007 |
tu |
008 |
910429s1991 ne ||||| 00| ||eng c |
016 |
7 |
|
|a 0444814221
|2 UK
|
020 |
|
|
|a 0444814221
|9 0-444-81422-1
|
035 |
|
|
|a (DE-627)1613092326
|
035 |
|
|
|a (DE-576)032707320
|
035 |
|
|
|a (DE-599)BSZ032707320
|
035 |
|
|
|a (OCoLC)246493501
|
035 |
|
|
|a (OCoLC)23081650
|
035 |
|
|
|a (DE-604)8043399436
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
044 |
|
|
|c XA-NL
|c XD-US
|c XA-GB
|
050 |
|
0 |
|a RC645.73
|
060 |
|
0 |
|a W3 EX89 no. 956
|
060 |
|
0 |
|a WH 380 I612 1990m
|
082 |
0 |
|
|a 615/.718
|
082 |
0 |
|
|a 615.718
|
084 |
|
|
|a YC 2505
|2 rvk
|0 (DE-625)rvk/153202:12911
|
245 |
1 |
0 |
|a Myelodysplastic syndrome and cytokines
|b proceedings
|c Tamotsu Miyazaki; Fumimaro Takaku; Haruto Uchino [Hrsg.]
|
264 |
|
1 |
|a Amsterdam u.a.
|b Excerpta Medica u.a.
|c 1991
|
300 |
|
|
|a XII,325 S
|b graph. Darst
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
490 |
1 |
|
|a International congress series
|v 956
|
500 |
|
|
|a Literaturangaben
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
650 |
|
0 |
|a Myelodysplastic syndromes
|x Drug therapy
|x Congresses
|
650 |
|
0 |
|a Hematopoietic stem cells
|x Drug effects
|x Congresses
|
650 |
|
0 |
|a Leukemia, myeloid
|x Drug therapy
|x Congresses
|
650 |
|
4 |
|a Humans++Blood++Biochemistry
|
653 |
|
0 |
|a Myelodysplastic syndromes
|a Immunotherapy
|a Congresses
|
653 |
|
0 |
|a Cytokines
|a Therapeutic use
|a Congresses
|
653 |
|
0 |
|a Cytokines
|a pharmacology
|a congresses
|
653 |
|
0 |
|a Cytokines
|a therapeutic use
|a congresses
|
653 |
|
0 |
|a Hematopoiesis
|a drug effects
|a congresses
|
653 |
|
0 |
|a Hematopoietic Stem Cells
|a drug effects
|a congresses
|
653 |
|
0 |
|a Leukemia, Myeloid
|a drug therapy
|a congresses
|
653 |
|
0 |
|a Myelodysplastic Syndromes
|a drug therapy
|a congresses
|
655 |
|
7 |
|a Konferenzschrift
|y 1990
|z Sapporo
|0 (DE-588)1071861417
|0 (DE-627)826484824
|0 (DE-576)433375485
|2 gnd-content
|
655 |
|
7 |
|a Konferenzschrift
|0 (DE-588)1071861417
|0 (DE-627)826484824
|0 (DE-576)433375485
|2 gnd-content
|
689 |
0 |
0 |
|D s
|0 (DE-588)4281183-1
|0 (DE-627)10422830X
|0 (DE-576)210765631
|a Myelodysplastisches Syndrom
|2 gnd
|
689 |
0 |
1 |
|D s
|0 (DE-588)4205701-2
|0 (DE-627)104317051
|0 (DE-576)21017045X
|a Cytokine
|2 gnd
|
689 |
0 |
|
|5 (DE-627)
|
689 |
1 |
0 |
|D s
|0 (DE-588)4205701-2
|0 (DE-627)104317051
|0 (DE-576)21017045X
|a Cytokine
|2 gnd
|
689 |
1 |
1 |
|D s
|0 (DE-588)4220765-4
|0 (DE-627)104375728
|0 (DE-576)210267593
|a Myelodysplasie
|2 gnd
|
689 |
1 |
|
|5 (DE-627)
|
700 |
1 |
|
|a Miyazaki, Tamotsu
|e hrsg
|4 edt
|
700 |
1 |
|
|a Takaku, Fumimaro
|e hrsg
|4 edt
|
700 |
1 |
|
|a Uchino, Haruto
|e hrsg
|4 edt
|
711 |
2 |
|
|a International Symposium on Myelodysplastic Syndrome and Cytokine
|d 1990
|c Sapporo
|0 (DE-588)5032117-1
|0 (DE-627)103520147
|0 (DE-576)193904322
|4 oth
|
711 |
2 |
9 |
|a International symposium on myelodysplastic syndrome and cytokine
|c Sapporo
|d 1990.09.28-29
|
830 |
|
0 |
|a Excerpta medica / International congress series
|v 956
|9 956
|w (DE-627)130706760
|w (DE-576)000604607
|w (DE-600)962777-7
|x 0531-5131
|7 ns
|
889 |
|
|
|w (DE-627)018363709
|
889 |
|
|
|w (DE-627)272271748
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a ISIL_DE-1a
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a ISIL_DE-7
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a ISIL_DE-15
|
912 |
|
|
|a GBV_ILN_2021
|
912 |
|
|
|a ISIL_DE-289
|
935 |
|
|
|i mdedup
|
936 |
r |
v |
|a YC 2505
|b Kongress, Tagungsbericht, Fortbildungslehrgang, Symposium
|k Medizin
|k Innere Medizin
|k Spezielle Innere Medizin
|k Klinische Hämatologie, Blut, Blutbildendes Gewebe, Milz
|k Spezielle klinische Hämatologie
|k Leukozytäres System: Leukämie (Leukose), Myelose, Agranulozytose, Tumorbildende Leukämieformen, Lymphatische Leukämie, Chronische Lymphadenose, Chlorom
|k A. Formalschlüssel
|k Kongress, Tagungsbericht, Fortbildungslehrgang, Symposium
|0 (DE-627)1271713985
|0 (DE-625)rvk/153202:12911
|0 (DE-576)201713985
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 615/.718
|
953 |
|
|
|2 045F
|a 615.718
|
980 |
|
|
|2 11
|1 01
|x 0001
|b 023376716
|c 00
|f 2
|d 1 A 94535
|e u
|j --%%--
|y r
|z 08-10-91
|
980 |
|
|
|2 11
|1 02
|x 0001
|b 68632708X
|c 00
|f 6
|d 29 SA 1775-956
|e u
|j --%%--
|y r
|z 30-11-04
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 100337554
|c 00
|f --%%--
|d 2713-1475
|e --%%--
|j --%%--
|y z
|z 18-02-93
|
980 |
|
|
|2 40
|1 01
|x 0007
|b 020399944
|c 00
|f MAG-MED
|d XZ 4101:956 =ZA 23934:956
|e u
|j --%%--
|c 09
|f --%%--
|d ZA 23934:956
|e --%%--
|j --%%--
|y xsn
|z 20-02-95
|
980 |
|
|
|2 2010
|1 01
|x DE-15
|b 3172767841
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 07-04-93
|
980 |
|
|
|2 2021
|1 01
|x DE-289
|b 317276799X
|c 00
|f S
|d WH 380/1990 M
|e --%%--
|j --%%--
|y l01
|z 11-11-93
|
982 |
|
|
|2 2021
|1 01
|x DE-289
|8 00
|s s
|0 (DE-627)1305909178
|a Myelodysplastic syndromes. Drug therapy. Congresses
|
982 |
|
|
|2 2021
|1 01
|x DE-289
|8 01
|s s
|0 (DE-627)1305909186
|a Leukemia, myeloid. Drug therapy. Congresses
|
982 |
|
|
|2 2021
|1 01
|x DE-289
|8 02
|s s
|0 (DE-627)1305909194
|a Hematopoietic stem cells. Drug effects. Congresses
|
983 |
|
|
|2 11
|1 00
|x DE-1a
|8 00
|0 (DE-627)288200764
|a Med F 591; Zytokine
|
983 |
|
|
|2 11
|1 00
|x DE-1a
|8 01
|0 (DE-627)284684910
|a Med H 1891; Leukämie
|
983 |
|
|
|2 11
|1 00
|x DE-1a
|8 02
|0 (DE-627)284996874
|a Med H 1291; Hämatopoese
|
984 |
|
|
|2 11
|1 01
|x 0001
|a 108380873010
|
984 |
|
|
|2 20
|1 01
|x 0084
|a 84$027131473
|
984 |
|
|
|2 40
|1 01
|x 0007
|a 7$107974762
|